Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
BeOne Medicines
Novartis
Chordia Therapeutics, Inc.
GluBio Therapeutics Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
Janssen Research & Development, LLC
TScan Therapeutics, Inc.
Bristol-Myers Squibb
Seagen Inc.
Changchun GeneScience Pharmaceutical Co., Ltd.
Taiho Oncology, Inc.
Incyte Corporation
Inmune Bio, Inc.
Servier
Novartis
Remedy Plan, Inc.
Sumitomo Pharma America, Inc.
Curis, Inc.
CareDx
Shattuck Labs, Inc.
AstraZeneca
Swedish Orphan Biovitrum
Takeda
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Disc Medicine, Inc
Orca Biosystems, Inc.
Auron Therapeutics, Inc.
Gamida Cell ltd
Ossium Health, Inc.
Orca Biosystems, Inc.
Faron Pharmaceuticals Ltd
NextCure, Inc.
Prelude Therapeutics
Cullinan Therapeutics Inc.
Orca Biosystems, Inc.
Novartis
MacroGenics
Novartis
Geron Corporation
Janssen Research & Development, LLC
Sanofi
medac GmbH
Celgene
Kahr Medical
Incyte Corporation
Taiho Oncology, Inc.
Takeda
Massive Bio, Inc.